Stockreport

AstraZeneca Oncology Updates Prompt Fresh Look At Valuation And Growth Potential [Yahoo! Finance]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Health Canada has approved AstraZeneca's Koselugo for adults with neurofibromatosis type 1 and inoperable plexiform neurofibromas. The US FDA has granted Priority Rev [Read more]